FRANCISCO PARTNERS IV, L.P.
SEC CIK 1622902 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | 10% | 0 | — | $9.68M | 4 | 2026-08-19 | 2026-08-24 |
Most active insiders at GDRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRANCISCO PARTNERS IV, L.P. | 10% | — | $9.68M |
| 2 | SEA VII Management, LLC | 10% | — | $95.1K |
| 3 | Fengler Justin | See Remarks | — | — |
| 4 | Chan Thomas (TC) | CAO | — | — |
| 5 | Barnes Wendy Lynn | See Remarks, Dir | — | — |
| 6 | Nabiey Romin | CAO | — | — |
| 7 | Hirsch Douglas Joseph | Dir | — | — |
| 8 | Bezdek Trevor | Dir | — | — |
| 9 | McGinnis Christopher A | See Remarks | — | — |
| 10 | Bruehlman Ronald E | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-08-26 21:20 | 2026-08-24+ | GDRX | GoodRx Holdings, Inc. | FRANCISCO PARTNERS IV, L.P. | 10% | S - Sale | $3.50 | -1.57M | 0 | -100% | -$5.48M |
| DMI | 2026-08-21 21:38 | 2026-08-19 | GDRX | GoodRx Holdings, Inc. | FRANCISCO PARTNERS IV, L.P. | 10% | C - Cnv Deriv | — | +7.50M | 2.50M | New | — |
| DMI | 2026-08-21 21:38 | 2026-08-19 | GDRX | GoodRx Holdings, Inc. | FRANCISCO PARTNERS IV, L.P. | 10% | J - Other | $0.00 | -4.74M | 1.36M | -78% | $0 |
| DMI | 2026-08-21 21:38 | 2026-08-19+ | GDRX | GoodRx Holdings, Inc. | FRANCISCO PARTNERS IV, L.P. | 10% | S - Sale | $3.52 | -1.19M | 777.2K | -61% | -$4.20M |
Purchase Sale Sale after option exercise All abbreviations